Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Neuropathic pain: diagnosis and treatment.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Analysis of neuromuscular parameters in patients with multiple sclerosis and gait disorders.
Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Towards a Quantitative OCT Image Analysis.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
Optimizing treatment success in multiple sclerosis.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Neurology issues in schizophrenia.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
Impaired early B cell tolerance in patients with rheumatoid arthritis.

Pages